Cargando…
Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36
BACKGROUND: Cluster of differentiation 36 (CD36) is reported to function as a receptor of erythrocytes infected with Plasmodium falciparum (PF) and as an oxidized low-density lipoprotein (oxLDL). AIM: The aim of this study was to investigate the impact of CD36 in PF parasitized red blood cells in hi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877532/ https://www.ncbi.nlm.nih.gov/pubmed/24404553 http://dx.doi.org/10.4103/1947-2714.123255 |
_version_ | 1782297669092245504 |
---|---|
author | Hijazi, Hassan Waggiallah, Hisham Alagib, Atif |
author_facet | Hijazi, Hassan Waggiallah, Hisham Alagib, Atif |
author_sort | Hijazi, Hassan |
collection | PubMed |
description | BACKGROUND: Cluster of differentiation 36 (CD36) is reported to function as a receptor of erythrocytes infected with Plasmodium falciparum (PF) and as an oxidized low-density lipoprotein (oxLDL). AIM: The aim of this study was to investigate the impact of CD36 in PF parasitized red blood cells in high concentration of oxLDL of T2 diabetes mellitus patients. MATERIAL AND METHODS: This cross-sectional study was conducted among diabetic patients. A total of 45 samples were collected from diabetic patients with more than 8% of HbA1c and more than 170 mg/dL of oxLDL. RESULTS: The mean difference between CD36 negative and positive controls was found to be statistically significant (P ≤ 0.001). The mean difference between CD36 positive control and CD36 in diabetic patients with oxLDL ≥ 170 mg/dL also was statistically significant. CONCLUSION: High concentration of oxidative low density of lipoprotein more than 170 mg/dL leads to block CD36 receptor on infected red blood. This process believed to contribute in parasite survival by avoiding phagocytic clearance in the spleen. |
format | Online Article Text |
id | pubmed-3877532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-38775322014-01-08 Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36 Hijazi, Hassan Waggiallah, Hisham Alagib, Atif N Am J Med Sci Original Article BACKGROUND: Cluster of differentiation 36 (CD36) is reported to function as a receptor of erythrocytes infected with Plasmodium falciparum (PF) and as an oxidized low-density lipoprotein (oxLDL). AIM: The aim of this study was to investigate the impact of CD36 in PF parasitized red blood cells in high concentration of oxLDL of T2 diabetes mellitus patients. MATERIAL AND METHODS: This cross-sectional study was conducted among diabetic patients. A total of 45 samples were collected from diabetic patients with more than 8% of HbA1c and more than 170 mg/dL of oxLDL. RESULTS: The mean difference between CD36 negative and positive controls was found to be statistically significant (P ≤ 0.001). The mean difference between CD36 positive control and CD36 in diabetic patients with oxLDL ≥ 170 mg/dL also was statistically significant. CONCLUSION: High concentration of oxidative low density of lipoprotein more than 170 mg/dL leads to block CD36 receptor on infected red blood. This process believed to contribute in parasite survival by avoiding phagocytic clearance in the spleen. Medknow Publications & Media Pvt Ltd 2013-12 /pmc/articles/PMC3877532/ /pubmed/24404553 http://dx.doi.org/10.4103/1947-2714.123255 Text en Copyright: © North American Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Hijazi, Hassan Waggiallah, Hisham Alagib, Atif Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36 |
title | Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36 |
title_full | Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36 |
title_fullStr | Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36 |
title_full_unstemmed | Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36 |
title_short | Oxidative Low Density Lipoprotien Prohibited Plasmodium Falciparum Clearance in type 2 Diabetes Mellitus Via Cluster Differentiation 36 |
title_sort | oxidative low density lipoprotien prohibited plasmodium falciparum clearance in type 2 diabetes mellitus via cluster differentiation 36 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877532/ https://www.ncbi.nlm.nih.gov/pubmed/24404553 http://dx.doi.org/10.4103/1947-2714.123255 |
work_keys_str_mv | AT hijazihassan oxidativelowdensitylipoprotienprohibitedplasmodiumfalciparumclearanceintype2diabetesmellitusviaclusterdifferentiation36 AT waggiallahhisham oxidativelowdensitylipoprotienprohibitedplasmodiumfalciparumclearanceintype2diabetesmellitusviaclusterdifferentiation36 AT alagibatif oxidativelowdensitylipoprotienprohibitedplasmodiumfalciparumclearanceintype2diabetesmellitusviaclusterdifferentiation36 |